Biotech in Flanders: a stunning story
The Flemish biotech sector is world-renowned. Flanders is a world player in ?life sciences?, the study of all life forms, and in particular in biotechnology, the practical application of that knowledge through technology. Thanks to a fruitful cross-fertilization between high quality healthcare, exce...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Kapellen
Witsand Publishers
[2023]
|
| Schlagworte: | |
| Zusammenfassung: | The Flemish biotech sector is world-renowned. Flanders is a world player in ?life sciences?, the study of all life forms, and in particular in biotechnology, the practical application of that knowledge through technology. Thanks to a fruitful cross-fertilization between high quality healthcare, excellent scientific research, daring entrepreneurship, risky financing and a supportive government, an academic and industrial network has emerged in Flanders over the past forty years that is considered unique in Europe. ?Flanders Biotech Valley?, between Meuse and North Sea, has become synonymous with quality.0In those 40 years, Flemish researchers and pioneers have made discoveries that affect more than two million patients a year and are used daily in agriculture, labs and medical cabinets. Entrepreneurs and their teams have had hundreds of meetings to convince investors to back these Flemish innovations and their story over all those other investment proposals that landed on their desks. With success. More than 10 billion euros found its way through Euronext, Nasdaq, Easdaq or private investments to Flemish biotech companies. Every euro invested in the sector became at least four euros ten years later, and every euro the Flemish government invested in the research of the Flemish Institute of Biotechnology (VIB) is worth eleven euros today. Some sixty thousand people today work directly or through supporting jobs in the Flemish biotech sector. That is a stunning story, without question. 0This book is based on interviews with dozens of privileged witnesses to the story of Flemish biotech and on a great many public documents and reports. It answers questions such as: what is a cell and how did we evolve in half a century from the first tentative sketch of the DNA molecule to profound insights into the role of genes, proteins, sugars and fats and in disease and health of humans, animals and plants? |
| Beschreibung: | 397 Seiten Illustrationen 31 cm |
| ISBN: | 9789493292260 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049534781 | ||
| 003 | DE-604 | ||
| 005 | 20240617 | ||
| 007 | t | ||
| 008 | 240206s2023 a||| |||| 00||| eng d | ||
| 020 | |a 9789493292260 |9 978-94-9329-226-0 | ||
| 035 | |a (OCoLC)1443581206 | ||
| 035 | |a (DE-599)BVBBV049534781 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-210 | ||
| 084 | |a HIST |q DE-210 |2 fid | ||
| 100 | 1 | |a Bury, Jo |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Biotech in Flanders |b a stunning story |c Jo Bury - Johan Cardoen - Dirk Reyn |
| 264 | 1 | |a Kapellen |b Witsand Publishers |c [2023] | |
| 264 | 4 | |c ©2023 | |
| 300 | |a 397 Seiten |b Illustrationen |c 31 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 520 | 3 | |a The Flemish biotech sector is world-renowned. Flanders is a world player in ?life sciences?, the study of all life forms, and in particular in biotechnology, the practical application of that knowledge through technology. Thanks to a fruitful cross-fertilization between high quality healthcare, excellent scientific research, daring entrepreneurship, risky financing and a supportive government, an academic and industrial network has emerged in Flanders over the past forty years that is considered unique in Europe. ?Flanders Biotech Valley?, between Meuse and North Sea, has become synonymous with quality.0In those 40 years, Flemish researchers and pioneers have made discoveries that affect more than two million patients a year and are used daily in agriculture, labs and medical cabinets. Entrepreneurs and their teams have had hundreds of meetings to convince investors to back these Flemish innovations and their story over all those other investment proposals that landed on their desks. With success. More than 10 billion euros found its way through Euronext, Nasdaq, Easdaq or private investments to Flemish biotech companies. Every euro invested in the sector became at least four euros ten years later, and every euro the Flemish government invested in the research of the Flemish Institute of Biotechnology (VIB) is worth eleven euros today. Some sixty thousand people today work directly or through supporting jobs in the Flemish biotech sector. That is a stunning story, without question. 0This book is based on interviews with dozens of privileged witnesses to the story of Flemish biotech and on a great many public documents and reports. It answers questions such as: what is a cell and how did we evolve in half a century from the first tentative sketch of the DNA molecule to profound insights into the role of genes, proteins, sugars and fats and in disease and health of humans, animals and plants? | |
| 648 | 7 | |a Geschichte 1980-2023 |2 gnd |9 rswk-swf | |
| 650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wissenschaftlicher Fortschritt |0 (DE-588)4190101-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Flandern |0 (DE-588)4071249-7 |2 gnd |9 rswk-swf | |
| 651 | 7 | |a Belgien |0 (DE-588)4005406-8 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Belgien |0 (DE-588)4005406-8 |D g |
| 689 | 0 | 1 | |a Flandern |0 (DE-588)4071249-7 |D g |
| 689 | 0 | 2 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
| 689 | 0 | 3 | |a Biotechnologische Industrie |0 (DE-588)4208106-3 |D s |
| 689 | 0 | 4 | |a Wissenschaftlicher Fortschritt |0 (DE-588)4190101-0 |D s |
| 689 | 0 | 5 | |a Geschichte 1980-2023 |A z |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Cardoen, Johan |e Verfasser |4 aut | |
| 700 | 1 | |a Reyn, Dirk |e Verfasser |4 aut | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-034880318 | |
Datensatz im Suchindex
| _version_ | 1806960340764721152 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Bury, Jo Cardoen, Johan Reyn, Dirk |
| author_facet | Bury, Jo Cardoen, Johan Reyn, Dirk |
| author_role | aut aut aut |
| author_sort | Bury, Jo |
| author_variant | j b jb j c jc d r dr |
| building | Verbundindex |
| bvnumber | BV049534781 |
| ctrlnum | (OCoLC)1443581206 (DE-599)BVBBV049534781 |
| era | Geschichte 1980-2023 gnd |
| era_facet | Geschichte 1980-2023 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV049534781</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240617</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">240206s2023 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789493292260</subfield><subfield code="9">978-94-9329-226-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1443581206</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049534781</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-210</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">HIST</subfield><subfield code="q">DE-210</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bury, Jo</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biotech in Flanders</subfield><subfield code="b">a stunning story</subfield><subfield code="c">Jo Bury - Johan Cardoen - Dirk Reyn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Kapellen</subfield><subfield code="b">Witsand Publishers</subfield><subfield code="c">[2023]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">397 Seiten</subfield><subfield code="b">Illustrationen</subfield><subfield code="c">31 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">The Flemish biotech sector is world-renowned. Flanders is a world player in ?life sciences?, the study of all life forms, and in particular in biotechnology, the practical application of that knowledge through technology. Thanks to a fruitful cross-fertilization between high quality healthcare, excellent scientific research, daring entrepreneurship, risky financing and a supportive government, an academic and industrial network has emerged in Flanders over the past forty years that is considered unique in Europe. ?Flanders Biotech Valley?, between Meuse and North Sea, has become synonymous with quality.0In those 40 years, Flemish researchers and pioneers have made discoveries that affect more than two million patients a year and are used daily in agriculture, labs and medical cabinets. Entrepreneurs and their teams have had hundreds of meetings to convince investors to back these Flemish innovations and their story over all those other investment proposals that landed on their desks. With success. More than 10 billion euros found its way through Euronext, Nasdaq, Easdaq or private investments to Flemish biotech companies. Every euro invested in the sector became at least four euros ten years later, and every euro the Flemish government invested in the research of the Flemish Institute of Biotechnology (VIB) is worth eleven euros today. Some sixty thousand people today work directly or through supporting jobs in the Flemish biotech sector. That is a stunning story, without question. 0This book is based on interviews with dozens of privileged witnesses to the story of Flemish biotech and on a great many public documents and reports. It answers questions such as: what is a cell and how did we evolve in half a century from the first tentative sketch of the DNA molecule to profound insights into the role of genes, proteins, sugars and fats and in disease and health of humans, animals and plants?</subfield></datafield><datafield tag="648" ind1=" " ind2="7"><subfield code="a">Geschichte 1980-2023</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wissenschaftlicher Fortschritt</subfield><subfield code="0">(DE-588)4190101-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Flandern</subfield><subfield code="0">(DE-588)4071249-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Belgien</subfield><subfield code="0">(DE-588)4005406-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Belgien</subfield><subfield code="0">(DE-588)4005406-8</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Flandern</subfield><subfield code="0">(DE-588)4071249-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Biotechnologische Industrie</subfield><subfield code="0">(DE-588)4208106-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="4"><subfield code="a">Wissenschaftlicher Fortschritt</subfield><subfield code="0">(DE-588)4190101-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="5"><subfield code="a">Geschichte 1980-2023</subfield><subfield code="A">z</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cardoen, Johan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Reyn, Dirk</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-034880318</subfield></datafield></record></collection> |
| geographic | Flandern (DE-588)4071249-7 gnd Belgien (DE-588)4005406-8 gnd |
| geographic_facet | Flandern Belgien |
| id | DE-604.BV049534781 |
| illustrated | Illustrated |
| index_date | 2024-07-03T23:27:33Z |
| indexdate | 2024-08-10T01:01:07Z |
| institution | BVB |
| isbn | 9789493292260 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034880318 |
| oclc_num | 1443581206 |
| open_access_boolean | |
| owner | DE-210 |
| owner_facet | DE-210 |
| physical | 397 Seiten Illustrationen 31 cm |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Witsand Publishers |
| record_format | marc |
| spelling | Bury, Jo Verfasser aut Biotech in Flanders a stunning story Jo Bury - Johan Cardoen - Dirk Reyn Kapellen Witsand Publishers [2023] ©2023 397 Seiten Illustrationen 31 cm txt rdacontent n rdamedia nc rdacarrier The Flemish biotech sector is world-renowned. Flanders is a world player in ?life sciences?, the study of all life forms, and in particular in biotechnology, the practical application of that knowledge through technology. Thanks to a fruitful cross-fertilization between high quality healthcare, excellent scientific research, daring entrepreneurship, risky financing and a supportive government, an academic and industrial network has emerged in Flanders over the past forty years that is considered unique in Europe. ?Flanders Biotech Valley?, between Meuse and North Sea, has become synonymous with quality.0In those 40 years, Flemish researchers and pioneers have made discoveries that affect more than two million patients a year and are used daily in agriculture, labs and medical cabinets. Entrepreneurs and their teams have had hundreds of meetings to convince investors to back these Flemish innovations and their story over all those other investment proposals that landed on their desks. With success. More than 10 billion euros found its way through Euronext, Nasdaq, Easdaq or private investments to Flemish biotech companies. Every euro invested in the sector became at least four euros ten years later, and every euro the Flemish government invested in the research of the Flemish Institute of Biotechnology (VIB) is worth eleven euros today. Some sixty thousand people today work directly or through supporting jobs in the Flemish biotech sector. That is a stunning story, without question. 0This book is based on interviews with dozens of privileged witnesses to the story of Flemish biotech and on a great many public documents and reports. It answers questions such as: what is a cell and how did we evolve in half a century from the first tentative sketch of the DNA molecule to profound insights into the role of genes, proteins, sugars and fats and in disease and health of humans, animals and plants? Geschichte 1980-2023 gnd rswk-swf Biotechnologie (DE-588)4069491-4 gnd rswk-swf Biotechnologische Industrie (DE-588)4208106-3 gnd rswk-swf Wissenschaftlicher Fortschritt (DE-588)4190101-0 gnd rswk-swf Flandern (DE-588)4071249-7 gnd rswk-swf Belgien (DE-588)4005406-8 gnd rswk-swf Belgien (DE-588)4005406-8 g Flandern (DE-588)4071249-7 g Biotechnologie (DE-588)4069491-4 s Biotechnologische Industrie (DE-588)4208106-3 s Wissenschaftlicher Fortschritt (DE-588)4190101-0 s Geschichte 1980-2023 z DE-604 Cardoen, Johan Verfasser aut Reyn, Dirk Verfasser aut |
| spellingShingle | Bury, Jo Cardoen, Johan Reyn, Dirk Biotech in Flanders a stunning story Biotechnologie (DE-588)4069491-4 gnd Biotechnologische Industrie (DE-588)4208106-3 gnd Wissenschaftlicher Fortschritt (DE-588)4190101-0 gnd |
| subject_GND | (DE-588)4069491-4 (DE-588)4208106-3 (DE-588)4190101-0 (DE-588)4071249-7 (DE-588)4005406-8 |
| title | Biotech in Flanders a stunning story |
| title_auth | Biotech in Flanders a stunning story |
| title_exact_search | Biotech in Flanders a stunning story |
| title_exact_search_txtP | Biotech in Flanders. A stunning story |
| title_full | Biotech in Flanders a stunning story Jo Bury - Johan Cardoen - Dirk Reyn |
| title_fullStr | Biotech in Flanders a stunning story Jo Bury - Johan Cardoen - Dirk Reyn |
| title_full_unstemmed | Biotech in Flanders a stunning story Jo Bury - Johan Cardoen - Dirk Reyn |
| title_short | Biotech in Flanders |
| title_sort | biotech in flanders a stunning story |
| title_sub | a stunning story |
| topic | Biotechnologie (DE-588)4069491-4 gnd Biotechnologische Industrie (DE-588)4208106-3 gnd Wissenschaftlicher Fortschritt (DE-588)4190101-0 gnd |
| topic_facet | Biotechnologie Biotechnologische Industrie Wissenschaftlicher Fortschritt Flandern Belgien |
| work_keys_str_mv | AT buryjo biotechinflandersastunningstory AT cardoenjohan biotechinflandersastunningstory AT reyndirk biotechinflandersastunningstory |